Women and von Willebrand disease

Haemophilia

Volumn 5, Issue SUPPL. 2, 1999, Pages 38-45

  Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Menorrhagia; PPH; Von Willebrand's disease; Women

Indexed keywords

VON WILLEBRAND FACTOR;

CONFERENCE PAPER; FEMALE; HUMAN; MENORRHAGIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VON WILLEBRAND DISEASE;

EID: 0032796253     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.0050s2038.x     Document Type: Conference Paper

References (44)

1. von Willebrand EA. Hereditär pseudohemofili. Finska Läkaresällskapets Handlinger 1926; Band LXVII (2): 7-111.
2. Hallberg I, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss-a population study. Acta Obstet Gynecol Scand 1996; 45: 320-51.
3. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br Obstet Gynaecol 1990; 97: 734-9.
4. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964; 16: 244-8.
5. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia, 1999: 5: 40-48.
6. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health and Social Security. Morbidity statistics from general practice. Third national study 1981-82. Series MBS No 1, London, HMSO, 1986.
7. Bradlow J, Coulter A, Brooks P. Patterns of referral. Oxford: Health Services Research Unit 1992.
8. Evans PC. Obstetric and gynecologic patients with von Willebrand's disease. Obstet Gynecol 1971; 38: 37-43.
9. Fraser IS, McCarron G, Markham R, Resta T, Watts A. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet Gynecol 1986; 68: 330-3.
10. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
11. Nilsson IM. Von Willebrand's disease-fifty years old. Acta Med Scand 1997; 201: 97-508.
12. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
13. Werner EJ, Broxson EH, Tucker El Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
14. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-8.
15. Short RV. The evolution of human reproduction. Proc R Soc Lond 1976; 195: 3-24.
16. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4: 836-41.
17. Kouides PA. Females with von Willebrand disease: 72 years as the silent majority. Haemophilia 1998; 4: 665-76.
18. Lethagen S, Harris A, Nilsson IM. Intranasal desmopressin (DDAVP) by spray in mild haemophilia A and von Willebrand's disease type 1. Blut 1990; 60: 187-91.
19. Rose EH, Aledort LM. Nasal spray desmopressin (DDAVP) for mild haemophilia A and von Willebrand disease. Ann Intern Med 1991; 114: 563-8.
20. Lethagen S, Ragnarson Tennvall G. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Ann Hematol 1993; 66: 257-60.
21. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996; 76: 692-6.
22. Kobrinsky N, Goldsmith J. Efficacy of stimate (desmopressin acetate) nasal spray, 1.5 ng/ml, for the treatment of menorrhagia in women with inherited bleeding disorders. Blood 1997; 90: 3186 (abstract).
23. Cederblad G, Hahn L, Korsan-Bengtsen K, Pehrsson NG, Rybo G. Variations in blood coagulation, fibrinolysis, platelet function and various plasma proteins during the menstrual cycle. Haemostasis 1997; 6: 294-302.
24. Hahn L, Cederblad G, Rybo G, Pehrsson NG, Bengtsen KK. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss. Br J Obstet Gynaecol 1976; 83: 974-80.
25. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled tiral of ethamsylate, mefenamic acid, and tranexamic acid. Br Med J 1996; 313: 579-82.
26. Ong YL, Hull DR, Mayne EE. Menorrhagia in von Willebrand disease successfully treated with a single daily dose tranexamic acid. Haemophilia 1998; 4: 63-5.
27. Chullapram T, Song JY, Fraser IS. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation. Obstet Gynecol 1996; 88: 71-6.
28. Stirling Y, Woolf L, North WRS, Senghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thrombos Haemostas 1984; 52: 17-82.
29. Adashi EY. Lack of improvement in von Willebrand's disease during pregnancy. N Engl J Med 1980; 303: 1178.
30. Conti M, Mori D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand's disease. Obstet Gynaecol 1986; 68: 282-5.
31. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R. Investigation and management of haemorrhagic disorders in pregnancy. J Clin Path 1994; 47: 100-8.
32. Greer IA, Lowe GDO, Walker JJ, Forbes CD. Haemorrhagic problems in Obstetrics and Gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 908-18.
33. Noller KL, Bowie EJW, Kempers RD. von Willebrand's disease in pregnancy. Obstet Gynaecol 1973; 41: 865-72.
34. Krishnamurthy M, Miotti AB. Von Willebrand's disease and pregnancy. Obstet Gynaecol 1977; 49: 244-7.
35. Hanna W, McCarroll D, Mcdonal T et al. Variant von Willebrand's disease and pregnancy. Blood 1981; 58: 873-9.
36. Lipton Ra Ayromlooi J, Collier BS. Severe von Willebrand's disease during labour and delivery. JAMA 1982; 248: 1355-7.
37. Chediak JR, Alban G, Maxey B. von Willebrand disease in pregnancy. Management during delivery and outcome of offspring. Am J Obstet Gynaecol 1986; 155: 618-24.
38. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R. Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force. J Clin Pathol 1994; 47: 100-8.
39. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1: 140-4.
40. South J, Naldret J. The effect of vaginal bleeding in early pregnancy on the infant born after the 28th week of pregnancy. J Obstet Gynaecol Br Commwlth 1973; 80: 236-41.
41. Kadir RA, Sabin CA, Pollard D, Economides DL, Lee CA. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314-21.
42. Beischer NA, Mackay EV. Obstetrics and the Newborn, 2nd edn. London: Ballière Tindall 1986.
43. Anonymous. Guidelines for the diagnosis and management of von Willebrand disease. Haemophilia 1997; 3(Suppl. 2): 4-8.
44. Mannucci PM. Treatment of von Willebrand disease. J Int Med 1997; 242(Suppl. 740): 129-32.